$11.38
-0.29-2.49%
At close: Nov 13, 4:00 PM EST
Amarin Corp PLC
AMRNNASDAQ
Amarin fell 29.1% from $16.04 to $11.38, behind the S&P 500's +13.3%. Its worst day was Dec 8 (−9.8%), and its low came Oct 16 at $11.32.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Amarin closed at its highest level of the year, 5.9% above where the year started.
+1.6% · S&P 500 +0.4%
Amarin shares fell 9.8%, while the S&P 500 fell 0.3%.
−9.8%, the year's worst day · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
Amarin Corporation plc (NASDAQ:AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced select preliminary unaudited 2025 financial highlights, provided a summary of key 2025
+16.9%, the year's best day · S&P 500 0.0%
Amarin shares rose 8.0%, while the S&P 500 rose 0.5%.
+8.0% · S&P 500 +0.5%
EPS of $0.01 beat the $-0.56 estimate on $49.2M revenue (est. $50.7M).
−9.5% · S&P 500 +0.8%
Amarin shares rose 9.5%, while the S&P 500 fell 0.2%.
+9.5% · S&P 500 −0.2%
EPS of $0.00 beat the $-0.41 estimate on $45.1M revenue (est. $43.4M).
+2.4% · S&P 500 0.0%
EPS of $0.00 beat the $-0.12 estimate on $42.2M revenue (est. $44.6M).
+1.5% · S&P 500 −1.5%
Amarin closed at its lowest level of the year, 29.4% below where the year started.
−2.2% · S&P 500 −1.1%
EPS of $0.08 beat the $-0.07 estimate on $39.5M revenue (est. $44.0M).
+6.7% · S&P 500 +0.3%
Where it ended: a close of $11.38 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $-0.07, revenue est. $49.5M).
Nothing in the past 12 months.
All AMRN dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AMRN and SPY from Benzinga historical bars. Not investment advice.
